Tech Company Financing Transactions
Altea Therapeutics Funding Round
Amylin Pharmaceuticals and Lilly Ventures invested in a funding round for Altea Therapeutics. The round was recorded on 4/2/2009.
Transaction Overview
Company Name
Announced On
4/2/2009
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
387 Technology Cir. NW 100
Atlanta, GA 30313
USA
Atlanta, GA 30313
USA
Phone
Website
Email Address
Overview
Altea Therapeutics is an emerging private pharmaceutical company focused on developing and commercializing a broad portfolio of pharmaceutical products based on a new class of advanced transdermal patches that deliver sustained therapeutic levels of proteins and water-soluble drugs in a convenient, painless and cost-effective manner.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Eric Tomlinson
VP - Bus. Development
Steven Damon
VP - Finance
Angela Walsh
VP - Product Management
Alan Smith
VP - R & D
Frank Tagliaferri
VP - Regulatory Affairs
Alexander Jacks
Browse more venture capital transactions:
Prev: 4/2/2009: Swype venture capital transaction
Next: 4/2/2009: Lilliputian Systems venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs